Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZC3H10 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | ZCCHC3 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-07 |
mRNA | SCAF4 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | SREBF2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | ZBTB39 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | ZBTB5 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | PBRM1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | VASN | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | DAZAP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |